The prevalence of diabetes and stress hyperglycemia in the acute myocardial infarction patients;Avaliação da prevalência do diabetes e da hiperglicemia de estresse no infarto agudo do miocárdio

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 3, 2008, Pages 465-472

  Lerario, Antonio Carlos ^a,b   Martins Coretti, Fabiana M L ^a   De Oliveira, Sergio Ferreira ^a   Betti, Roberto Tadeu Barcelos ^a   Bastos, Maria Do Socorro C B ^a   Ferri, Letícia De Araujo Funari ^a   Garcia, Rosa Maria Rahmi ^a   Wajchenberg, Bernardo Leo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FMUSP ^*  (Brazil)

Author keywords

Complications of diabetes; Diabetes and cardiovascular heart disease; Myocardial infarction

Indexed keywords

EID: 44949166815     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000300006     Document Type: Article

References (41)

1. King H, Albert RE, Herman WH. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-31.
2. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care. 2001;24:1936-40.
3. Ministério da Saúde do Brasil e Organização Panamericana da Saúde (OPAS). Avaliação do Plano de Reorganização da Hipertensão Arterial e o Diabetes Mellitus no Brasil 2004; 23-47.
4. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44 (Suppl 2):S14-S21.
5. Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atheroclerotic risk factors, prevalence and coronary hearth disease. Am J Cardiol. 2000;86:897-902.
6. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-81.
7. Meigs JB. Epidemiology of cardiovascular complications in type 2 diabetes. Acta Diabetol. 2003;40:S358-61.
8. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1999;241:2035-8.
9. Lessa I. Relative mortality trends for diabetes mellitus in the Brazilian state capitals (1950-1985). Bol Oficina Sanit Panam. 1992;113(3):212-7.
10. Balkau B, Rschwege E. Insulin resistance: an independent risk factor for cardiovascular disease? Diabetes Obes Metab. 1999;Suppl1:S23-31.
11. Gu K, Connie CC, Harris MI. Diabetes and decline in hearth disease mortality in US adults. JAMA. 1999;281:1291.
12. American Diabetes Association , Clinical Practice Recommendations: 2006 Diagnosis and Classification of Diabetes mellitus. Diabetes Care. 2006;29:S43-48.
13. Meigs JB, Nathan DM, D'Agostino RB Sr. Wilson PW Fasting and post-challenge glycemia and cardiovascular disease risk: the Framingham Off-Spring Study. Diabetes Care. 2002;25:1845-50.
14. DECODE Study Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161:397-405.
15. Hu FB, Stamper MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease of type 2 diabetes. Diabetes Care. 2002;25:1129-34.
16. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.
17. Oswald G, Smith C, Betteridge J, Yudkin J. Determinants and importance of stress hyperglycemia in non-diabetic patients with myocardial infarction. Br Med J. 1986;293:917-22.
18. Nordin C, Amirrudin R, Ricker L, Choi J, Marantz PR. Diabetes and stress hyperglycemia with myocardial infarctions and an urban municipal hospital: prevalence and effect on mortality Cardiol Rev. 2005;13:223-30.
19. Norhammar AM, Rydèn L, Malmberg K. Admission Plasma Glucose - Independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care. 1999;22:1827-31.
20. Foo K, Cooper J, Deaner A, Knigh C, Suliman A, Ranjadoyalan K, et al. A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndrome. Heart. 2003;89:512-6.
21. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: A independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-82.
22. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. Diabetes Care. 1999;22:233-40.
23. Northammar A, Tenerz A, Nilsson G. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-4.
24. Duarte ER, Pellanda LC, Portal VL. Inflammatory, lipid, and metabolic profile in acute ischemic syndrome. Correlation with hospital and post-hospital events. Arq Bras Cardiol. 2005;84:122-9.
25. World Health organization Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1 Diagnosis and classification of diabetes mellitus 1999.
26. Instituto Brasileiro de Geografia e Estatística IBGE. Estatísticas de indicadores sociais. Disponível em: www.ibge/pop.gov.br. (Acesso em 20 dez 2006).
27. Fundação Estadual de Análise de Dados - Seade. Disponível em: www.seade.gov.br. (Acesso em 20 dez 2006).
28. Ministério da Saúde do Brasil. Censo nacional sobre a prevalência de diabetes no Brasil 1989. Disponível em: www.diabetes.org.br (Acesso em 20 dez 2006).
29. Donahue SM, Steward GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP et al. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298:765-75.
30. Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA et al. Temporal trends in the treatment of over 1,5 million patients with myocardial infarction in U.S. from 1990 through 1999. J Am Coll Cardiol. 2000;36:2056-5063.
31. Petursson P, Herlitz J Caldahl K, From-Attebring M, Sjoland H, Gudbjornsdottir S et al. Association between glycometabolic status in the acute phase and 2 1/2 years after an acute coronary syndrome. Scand Cardiovasc J. 2006;40:45-51.
32. Wallander M, Bartnick M, Efendic S, Hamsten A, Malmberg O, Ohrvik J et al. A Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the Gami study. Diabetologia. 2005;45:2229-35.
33. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes. and prevalence of coronary hearth disease among NHANES III participants age 50 and older. Diabetes. 2003;52:1210-14.
34. Malmberg K, Ryden L, Efendic S, Herlitz J, Niol P, Walstrom A et al. Randomized trial of insulin glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (Digami Study ): effects on mortality at 1 year. J Am Coll Cardiol. 1995:26:57-65.
35. Aronson D, Rayfeld EJ, Chesebro JH. Mechanisms determining and outcome of diabetic patients who had an acute myocardial infarction. Ann Intern Med. 1997;126:296-306.
36. Lehto S, Pyorala K, Metiennen M. Myocardial infarct size and mortality in patients with non-insulin dependent diabetes mellitus. J Intern Med. 1994;236:291-7.
37. Orlander PR, Goff DC, Morrissey M, Ramsey DJ, Wear ML, Labarthe DR et al. The relation of diabetes to the severity of acute myocardial infarction and post-miocardial infarction survival in Mexican-American and Non-Hispanic whites The Corpus Christi Hearth Project. Diabetes. 1994;43:897-902.
38. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB et al. The effect of diabetes mellitus on the prognosis and serial ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic ventricular dysfunction to adverse prognosis The Milis Study Group. J Am Coll Cardiol. 1989;14:49-57.
39. Fava S, Azzopardi j, Muscat HA, Fenech FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care. 1993;16:1615-8.
40. Sobel BE, Frye R, Dedre KM. Burgeoning dilemmas in the management of diabetes and cardiovascular disease. Rationale for bypass angioplasty revascularization investigation 2 diabetes (Bari D2). Trial Circulation. 2003;107:636-42.
41. Stettler C, Allernann S, Egger M, Windecker S, Meier B, Diern P. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparisons of controlled. Heart. 2006; 92:650-7.